India’s Bharat Biotech has sought approval from the authorities to hold clinical trials of its coronavirus vaccine candidate COVAXIN in Bangladesh.

The company applied for the approval around two weeks ago, said Dr Syed Modasser Ali, the chairman of Bangladesh Medical Research Council.

The application for the phase three trial has been sent to the council’s Ethical Review Committee for scrutiny, he said on Friday.